Search Our Scientific Publications & Authors

Acta Cardiol 2023 Sep 19:1-2. Epub 2023 Sep 19.

Clinical Research Unit, Special Unit for Biomedical Research and Education (SUBRE), School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Acta Cardiol 2023 Sep;78(7):749-753

Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium.

Acta Cardiol 2023 Sep 12:1-3. Epub 2023 Sep 12.

Department of Cardiology, Centro Hospitalar de Setúbal, Setúbal, Portugal.

Acta Cardiol 2023 Sep 12:1-2. Epub 2023 Sep 12.

Department of Cardiology, Faculty of Medicine, Mugla Sitki Kocman University, Muğla, Turkey.

Acta Cardiol 2023 Sep 12:1-2. Epub 2023 Sep 12.

Department of Pathology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.

Acta Cardiol 2023 Sep 11. Epub 2023 Sep 11.

Department of Cardiology, Brugmann University Hospital, Brussels, Belgium.

Acta Cardiol 2023 Sep 11:1-12. Epub 2023 Sep 11.

International UNESCO center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.

Objective: To investigate the association between cardiovascular diseases (CVDs) and haematologic factors in a cohort of Iranian adults.

Method: For a total population of 9,704 aged 35 to 65, a prospective study was designed. Haematologic factors and demographic characteristics (such as gender, age, and smoking status) were completed for all participants. Read More

Acta Cardiol 2023 Sep 11:1-10. Epub 2023 Sep 11.

Department of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.

Background: The frequency of cardiovascular system involvement is increased in rheumatoid arthritis (RA) and may result in serious morbidity and mortality. Early intervention and control of the disease activity may reduce the risk of cardiovascular events. The purpose of this study is to examine the effects of steroids and methotrexate (Mtx) on the heart functions of newly diagnosed RA patients. Read More

Acta Cardiol 2023 Sep 11;78(7):828-837. Epub 2023 Sep 11.

Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Objectives: Acute heart failure (AHF) hospitalisation is associated with 10% mortality. Outpatient based management (OPM) of AHF appeared effective in observational studies. We conducted a pilot randomised controlled trial (RCT) comparing OPM with standard inpatient care (IPM). Read More

Acta Cardiol 2023 Aug 29:1-10. Epub 2023 Aug 29.

Wenling First People's Hospital, Wenling, China.

Background: The purpose of this systematic review and meta-analysis was to evaluate the common clinical adverse events associated with sodium/glucose cotransporter-2 inhibitor (SGLT2i) use compared to placebo in patients with chronic kidney disease (CKD) with or without type 2 diabetes.

Methods: Twelve articles were chosen a systematic search of the PubMed, Embase, and Cochrane Library databases. We screened for randomised placebo-controlled trials. Read More

Acta Cardiol 2023 Aug 29:1-2. Epub 2023 Aug 29.

Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.

Acta Cardiol 2023 Aug 29:1-2. Epub 2023 Aug 29.

Department of Cardiology, Universitair Ziekenhuis Brussel, Jette, Belgium.

Acta Cardiol 2023 Aug 22:1-7. Epub 2023 Aug 22.

Departments of Anesthesiology and Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was the main pathogen in the COVID-19 pandemic. This viral infection has been associated with several respiratory and non-respiratory complications contributing to a higher mortality rate, especially in patients with underlying heart diseases worldwide. Once considered a respiratory tract disease, it is now well-known that COVID-19 patients may experience a wide range of cardiac manifestations. Read More

Acta Cardiol 2023 Aug 22:1-6. Epub 2023 Aug 22.

Heart Clinic Ulm, Ulm, Germany.

Background: Myocardial deformation parameters have been shown to yield early detection of pathological changes in chronic heart failure (CHF). Aim of our study was to evaluate myocardial deformation changes under optimal medical therapy (OMT) in CHF patients.

Methods: CHF patients were examined longitudinally with two cardiac magnetic resonance imaging (CMR) examinations at a median time interval of 140 days. Read More

Acta Cardiol 2023 Sep 22;78(7):840-845. Epub 2023 Aug 22.

ANMCO Research Center, Heart Care Foundation, Florence, Italy.

Randomised clinical trials, observational studies, and meta-analyses have shown that sodium-glucose cotransporter 2 inhibitors (SGLT2-i) reduce the risk of hospitalisation for heart failure (HF), chronic kidney disease (CKD) progression, and mortality in patients with HF, irrespective of the presence of type 2 diabetes mellitus. However, real-world epidemiology may differ from clinical trial populations, thereby limiting generalisability and delaying the introduction of novel treatments in clinical practice.The aim of the present study was to assess the prevalence of DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure) inclusion criteria in a population of HF with reduced ejection fraction (HFrEF) patients enrolled in the Italian Network on Heart Failure (IN-HF) registry. Read More

Acta Cardiol 2023 Aug 15:1-10. Epub 2023 Aug 15.

Second Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.

Background: Echocardiographic markers of right ventricular dysfunction or pressure overload (RV) have been used in risk assessment of patients with acute pulmonary embolism (APE). Nevertheless, the role of echocardiography in these patients is incompletely determined. We evaluated the right ventricular function using 'non-conventional' markers of RV in patients with APE. Read More

Acta Cardiol 2023 Aug 15:1-9. Epub 2023 Aug 15.

CHU Ambroise Paré, Mons, Belgium.

Background: Fractional flow reserve (FFR) guided-percutaneous interventions is nowadays the gold standard for optimal coronary artery revascularization. While multiple pressure guidewires have been validated, the use of microcatheter for FFR measurements is still a matter of debate.

Objective: The aim of this study was to investigate the crossing profile characteristics of the NAVVUS microcatheter as compared with the COMET pressure wire. Read More

Acta Cardiol 2023 Aug 15. Epub 2023 Aug 15.

Department of Cardiology, Başakşehir Çam & Sakura City Hospital, Istanbul, Turkey.

Acta Cardiol 2023 Aug 15:1-2. Epub 2023 Aug 15.

Department of Cardiac Surgery, Wuhan Asia Heart Hospital, Wuhan University of Science and Technology, Wuhan, P.R. China.

Acta Cardiol 2023 Aug 15:1-2. Epub 2023 Aug 15.

Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Acta Cardiol 2023 Aug 15:1-2. Epub 2023 Aug 15.

Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.

Acta Cardiol 2023 Aug 15:1-8. Epub 2023 Aug 15.

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

Aims: To determine the association between all-cause mortality and low-density lipoprotein cholesterol (LDL-C) in patients with idiopathic cardiomyopathy (iDCM).

Background: LDL-C had long been considered as a dangerous predictor of cardiovascular diseases; however, the correlation between them was not fully clarified.

Methods: A total of 1058 patients who met the World Health Organization criteria for iDCM in West China Hospital (2009-2016) were enrolled in this retrospective study. Read More

Acta Cardiol 2023 Aug 15. Epub 2023 Aug 15.

Chandigarh University, Punjab, India.

Acta Cardiol 2023 Aug 15:1-2. Epub 2023 Aug 15.

Department of Cardiology, Başakşehir Çam & Sakura City Hospital, Istanbul, Turkey.

Interpretation of electrocardiographic changes after cardiac arrest is critical. If the electrocardiogram is consistent with ST-segment elevation myocardial infarction, primary coronary angiography is indicated. However, the presence of ST-segment depression in eight or more surface leads, together with ST-segment elevation in the aVR and/or V1, could be a sign of multivessel ischaemia or left main coronary artery disease if haemodynamic instability is present. Read More

Acta Cardiol 2023 Aug 15:1-2. Epub 2023 Aug 15.

Cardiology Resident, Trinidad Mitre Institute, Buenos Aires, Argentina.

Acta Cardiol 2023 Aug 14. Epub 2023 Aug 14.

Faculty of Medicine, Clinic of Cardiovascular Diseases, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.

Acta Cardiol 2023 Aug;78(6):639-643

Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium.

Acta Cardiol 2023 Jul 20:1-3. Epub 2023 Jul 20.

Cardiology Department, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Acta Cardiol 2023 Jul 20:1-2. Epub 2023 Jul 20.

Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.

Acta Cardiol 2023 Jul 20:1-11. Epub 2023 Jul 20.

Guangzhou Women and Children Medical Center, Guangzhou, China.

Background: Hypoxia-inducible factor-1alpha (HIF-1α) is a transcription factor implicated in physiological and pathological responses to hypoxia. The present study aims to investigate the effect and mechanism of HIF-1α on cardiopulmonary bypass (CPB)-related myocardial injury, thereby conferring a theoretical basis for the clinical treatment of myocardial injury in CPB.

Methods: An experimental model of CPB was established in rats by surgery. Read More